Lilly USA, LLC
Boehringer Ingelheim Pharmaceuticalas, Inc.
Novartis Pharmaceuticals Corporation
Topic: Lung Cancer
These symposia are intended to improve care of patients with lung cancer by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussions of novel agents at various stages of clinical development will be given significant focus. These enduring online activities are designed to provide clinical decision-making strategies for integration of novel therapeutic options.
This series consists of 3 continuing education webcasts.